Rates of growth vary dramatically in the for-profit oncology with mature markets with large outpatient radiotherapy sectors in France and Germany being left standing by growth rates in Emerging Markets such as India according to the latest report from HBI Intelligence. Surprisingly, the UK is also growing at 10%.



